MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kocarek, T. A.
Right arrow Articles by Reddy, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kocarek, T. A.
Right arrow Articles by Reddy, A. B.

Vol. 54, Issue 3, 474-484, September 1998

Regulation of Rat Hepatic Cytochrome P450 Expression by Sterol Biosynthesis Inhibition: Inhibitors of Squalene Synthase Are Potent Inducers of CYP2B Expression in Primary Cultured Rat Hepatocytes and Rat Liver

Thomas A. Kocarek, Janice M. Kraniak, and Anita B. Reddy

Institute of Chemical Toxicology, Wayne State University, Detroit, Michigan 48201

The effects of treatment with squalestatin 1, a potent inhibitor of squalene synthase, the first committed enzyme of sterol biosynthesis, were examined on cytochrome P450 expression in primary cultured rat hepatocytes and rat liver. Incubation of cultured hepatocytes with squalestatin 1 caused marked accumulations (maximal elevations that were ~25-100% of phenobarbital-elicited increases) of CYP2B mRNA and immunoreactive protein but not of CYP1A, CYP3A, or CYP4A. Squalestatin 1 treatment increased CYP2B and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA content in hepatocyte cultures with comparable potencies (ED50 = 5.0 and 18 nM, respectively), and significantly induced CYP2B (mRNA, immunoreactive protein, and pentoxyresorufin O-dealkylase activity) in the livers of treated rats, producing maximal increases at a dose of 25 mg/kg/day that were ~32-87% of phenobarbital-induced increases. Squalestatin 1 treatment induced both CYP2B1 and CYP2B2 and activated reporter gene expression in cultured hepatocytes transiently transfected with a plasmid containing ~2.4 kb of CYP2B1 gene 5'-flanking region or containing a previously described phenobarbital-responsive region. Coincubation of cultured hepatocytes with 25-hydroxycholesterol suppressed squalestatin 1-mediated CYP2B and 3-hydroxy-3-methylglutaryl coenzyme A mRNA induction with approximately the same potency. Treatment of cultures with SQ-34919, a structurally distinct squalene synthase inhibitor, produced the same selective CYP2B mRNA induction as did squalestatin 1. These results suggest that inhibition of hepatic sterol synthesis activates processes that culminate in increased CYP2B gene transcription.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
N. M. Jackson and T. A. Kocarek
Suppression of CYP2B Induction by Alendronate-Mediated Farnesyl Diphosphate Synthase Inhibition in Primary Cultured Rat Hepatocytes
Drug Metab. Dispos., October 1, 2008; 36(10): 2030 - 2036.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Weng, C. C. DiRusso, A. A. Reilly, P. N. Black, and X. Ding
Hepatic Gene Expression Changes in Mouse Models with Liver-specific Deletion or Global Suppression of the NADPH-Cytochrome P450 Reductase Gene: MECHANISTIC IMPLICATIONS FOR THE REGULATION OF MICROSOMAL CYTOCHROME P450 AND THE FATTY LIVER PHENOTYPE
J. Biol. Chem., September 9, 2005; 280(36): 31686 - 31698.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. Huang, J. Zhang, P. Wei, W. T. Schrader, and D. D. Moore
Meclizine Is an Agonist Ligand for Mouse Constitutive Androstane Receptor (CAR) and an Inverse Agonist for Human CAR
Mol. Endocrinol., October 1, 2004; 18(10): 2402 - 2408.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
H. Takagi, M. Shibutani, N. Kato, H. Fujita, K.-Y. Lee, S. Takigami, K. Mitsumori, and M. Hirose
Microdissected Region-specific Gene Expression Analysis with Methacarn-fixed, Paraffin-embedded Tissues by Real-time RT-PCR
J. Histochem. Cytochem., July 1, 2004; 52(7): 903 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. D. Shenoy, T. A. Spencer, N. A. Mercer-Haines, M. Abdolalipour, W. L. Wurster, M. Runge-Morris, and T. A. Kocarek
Induction of CYP3A by 2,3-Oxidosqualene:Lanosterol Cyclase Inhibitors Is Mediated by an Endogenous Squalene Metabolite in Primary Cultured Rat Hepatocytes
Mol. Pharmacol., May 1, 2004; 65(5): 1302 - 1312.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
S. D. Shenoy, T. A. Spencer, N. A. Mercer-Haines, M. Alipour, M. D. Gargano, M. Runge-Morris, and T. A. Kocarek
CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
Drug Metab. Dispos., January 1, 2004; 32(1): 66 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. A. Kocarek and N. A. Mercer-Haines
Squalestatin 1-Inducible Expression of Rat CYP2B: Evidence That an Endogenous Isoprenoid Is an Activator of the Constitutive Androstane Receptor
Mol. Pharmacol., November 1, 2002; 62(5): 1177 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
E. Schuetz, L. Lan, K. Yasuda, R. Kim, T. A. Kocarek, J. Schuetz, and S. Strom
Development of A Real-Time in Vivo Transcription Assay: Application Reveals Pregnane X Receptor-Mediated Induction of CYP3A4 by Cancer Chemotherapeutic Agents
Mol. Pharmacol., September 1, 2002; 62(3): 439 - 445.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Handschin, M. Podvinec, R. Amherd, R. Looser, J.-C. Ourlin, and U. A. Meyer
Cholesterol and Bile Acids Regulate Xenosensor Signaling in Drug-mediated Induction of Cytochromes P450
J. Biol. Chem., August 9, 2002; 277(33): 29561 - 29567.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
Z. Duanmu, T. A. Kocarek, and M. Runge-Morris
Transcriptional Regulation of Rat Hepatic Aryl Sulfotransferase (SULT1A1) Gene Expression by Glucocorticoids
Drug Metab. Dispos., August 1, 2001; 29(8): 1130 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
M. J. Callow, S. Dudoit, E. L. Gong, T. P. Speed, and E. M. Rubin
Microarray Expression Profiling Identifies Genes with Altered Expression in HDL-Deficient Mice
Genome Res., December 1, 2000; 10(12): 2022 - 2029.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
M. Runge-Morris, W. Wu, and T. A. Kocarek
Regulation of Rat Hepatic Hydroxysteroid Sulfotransferase (SULT2-40/41) Gene Expression by Glucocorticoids: Evidence for a Dual Mechanism of Transcriptional Control
Mol. Pharmacol., December 1, 1999; 56(6): 1198 - 1206.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
H. Yamada, Y. Matsuki, T. Yamaguchi, and K. Oguri
Effect of a Ligand Selective for Peripheral Benzodiazepine Receptors on the Expression of Rat Hepatic P-450 Cytochromes: Assessment of the Effect In Vivo and in a Hepatocyte Culture System
Drug Metab. Dispos., November 1, 1999; 27(11): 1242 - 1247.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics